Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

Masuishi T, Hara H, Ando T, Kawakami T, Yamamoto Y, Sugimoto N, Shiraishi K, Esaki T, Negoro Y, Tsuzuki T, Sawai H, Nakamura M, Inagaki T, Shinohara Y, Kawakami K, Mitani S, Tsuchihashi K, Kondoh C, Katsuya H, Maeda O, Fujita Y, Yoshimura K, Terashima M, Nakajima TE, Muro K

Open source

DOI
10.1007/s10120-026-01790-3
Published
2026 Aug 27
Container
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s10120-026-01790-3,
  title = {Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.},
  author = {Masuishi T and Hara H and Ando T and Kawakami T and Yamamoto Y and Sugimoto N and Shiraishi K and Esaki T and Negoro Y and Tsuzuki T and Sawai H and Nakamura M and Inagaki T and Shinohara Y and Kawakami K and Mitani S and Tsuchihashi K and Kondoh C and Katsuya H and Maeda O and Fujita Y and Yoshimura K and Terashima M and Nakajima TE and Muro K},
  year = {2026},
  journal = {Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association},
  doi = {10.1007/s10120-026-01790-3},
  url = {https://doi.org/10.1007/s10120-026-01790-3}
}

RIS

TY  - JOUR
TI  - Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.
AU  - Masuishi T
AU  - Hara H
AU  - Ando T
AU  - Kawakami T
AU  - Yamamoto Y
AU  - Sugimoto N
AU  - Shiraishi K
AU  - Esaki T
AU  - Negoro Y
AU  - Tsuzuki T
AU  - Sawai H
AU  - Nakamura M
AU  - Inagaki T
AU  - Shinohara Y
AU  - Kawakami K
AU  - Mitani S
AU  - Tsuchihashi K
AU  - Kondoh C
AU  - Katsuya H
AU  - Maeda O
AU  - Fujita Y
AU  - Yoshimura K
AU  - Terashima M
AU  - Nakajima TE
AU  - Muro K
PY  - 2026
JO  - Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
DO  - 10.1007/s10120-026-01790-3
UR  - https://doi.org/10.1007/s10120-026-01790-3
ER  - 

APA

T, M., H, H., T, A., T, K., Y, Y., N, S., K, S., T, E., Y, N., T, T., H, S., M, N., T, I., Y, S., K, K., S, M., K, T., C, K., H, K., O, M., Y, F., K, Y., M, T., TE, N., & K, M. (2026). Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.. Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association. https://doi.org/10.1007/s10120-026-01790-3

Source records